No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index

The National Heart, Lung, and Blood Institute Family Heart Study

Yuling Hong, Mark F. Leppert, Jennifer Lin, Steven Hunt, Stephen S. Rich, Donna K. Arnett, Richard H. Myers, John Eckfeldt, Roger R. Williams, Michael A. Province

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A major gene effect on the fasting insulin level and insulin resistance has been suggested in previous studies. Several candidate genes for insulin resistance in rare syndromes have been proposed. However, there has been limited success in finding genes for common forms of insulin resistance. There is accumulating evidence of a relationship between insulin resistance and a disturbance of free fatty acid (FFA) metabolism. The very-low-density lipoprotein (VLDL) receptor, which is associated with FFA metabolism, could serve as a possible candidate gene for insulin resistance. We performed linkage analyses between the VLDL receptor gene and fasting insulin and the homeostasis model assessment (HOMA) insulin resistance index (fasting insulin · fasting glucose/22.5) in 1,050 sibpairs participating in the phase II physical examination of the National Heart, Lung, and Blood Institute Family Heart Study (FHS). Data analyses were completed using the SIBPAL component of the SAGE software package (SAGE, Statistical Analysis for Genetic Epidemiology, Version 3.1; Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, 1997). We did not find evidence for linkage of the fasting insulin or the HOMA insulin resistance index with a polymorphic marker at the VLDL locus (P = .316 and .402, respectively). Adjustment of fasting insulin and the HOMA insulin resistance index for the body mass index (BMI) did not change the results (P = .319 and .472, respectively). In conclusion, no evidence was found for a linkage between a locus controlling the fasting insulin level or HOMA insulin resistance index and a VLDL polymorphism in the present study. Additional adjustment of fasting insulin or the HOMA insulin resistance index for the BMI did not change the linkage results significantly. (C) 2000 by W.B. Saunders Company.

Original languageEnglish
Pages (from-to)293-297
Number of pages5
JournalMetabolism: Clinical and Experimental
Volume49
Issue number3
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Insulin Resistance
Fasting
Homeostasis
Insulin
Serum
Genes
Social Adjustment
VLDL Lipoproteins
Nonesterified Fatty Acids
Body Mass Index
Software
Biostatistics
VLDL receptor
Molecular Epidemiology
Physical Examination
Epidemiology

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index : The National Heart, Lung, and Blood Institute Family Heart Study. / Hong, Yuling; Leppert, Mark F.; Lin, Jennifer; Hunt, Steven; Rich, Stephen S.; Arnett, Donna K.; Myers, Richard H.; Eckfeldt, John; Williams, Roger R.; Province, Michael A.

In: Metabolism: Clinical and Experimental, Vol. 49, No. 3, 2000, p. 293-297.

Research output: Contribution to journalArticle

Hong, Yuling ; Leppert, Mark F. ; Lin, Jennifer ; Hunt, Steven ; Rich, Stephen S. ; Arnett, Donna K. ; Myers, Richard H. ; Eckfeldt, John ; Williams, Roger R. ; Province, Michael A. / No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index : The National Heart, Lung, and Blood Institute Family Heart Study. In: Metabolism: Clinical and Experimental. 2000 ; Vol. 49, No. 3. pp. 293-297.
@article{1ddabf30be2645b58b82b4e3968afcbd,
title = "No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index: The National Heart, Lung, and Blood Institute Family Heart Study",
abstract = "A major gene effect on the fasting insulin level and insulin resistance has been suggested in previous studies. Several candidate genes for insulin resistance in rare syndromes have been proposed. However, there has been limited success in finding genes for common forms of insulin resistance. There is accumulating evidence of a relationship between insulin resistance and a disturbance of free fatty acid (FFA) metabolism. The very-low-density lipoprotein (VLDL) receptor, which is associated with FFA metabolism, could serve as a possible candidate gene for insulin resistance. We performed linkage analyses between the VLDL receptor gene and fasting insulin and the homeostasis model assessment (HOMA) insulin resistance index (fasting insulin · fasting glucose/22.5) in 1,050 sibpairs participating in the phase II physical examination of the National Heart, Lung, and Blood Institute Family Heart Study (FHS). Data analyses were completed using the SIBPAL component of the SAGE software package (SAGE, Statistical Analysis for Genetic Epidemiology, Version 3.1; Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, 1997). We did not find evidence for linkage of the fasting insulin or the HOMA insulin resistance index with a polymorphic marker at the VLDL locus (P = .316 and .402, respectively). Adjustment of fasting insulin and the HOMA insulin resistance index for the body mass index (BMI) did not change the results (P = .319 and .472, respectively). In conclusion, no evidence was found for a linkage between a locus controlling the fasting insulin level or HOMA insulin resistance index and a VLDL polymorphism in the present study. Additional adjustment of fasting insulin or the HOMA insulin resistance index for the BMI did not change the linkage results significantly. (C) 2000 by W.B. Saunders Company.",
author = "Yuling Hong and Leppert, {Mark F.} and Jennifer Lin and Steven Hunt and Rich, {Stephen S.} and Arnett, {Donna K.} and Myers, {Richard H.} and John Eckfeldt and Williams, {Roger R.} and Province, {Michael A.}",
year = "2000",
language = "English",
volume = "49",
pages = "293--297",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index

T2 - The National Heart, Lung, and Blood Institute Family Heart Study

AU - Hong, Yuling

AU - Leppert, Mark F.

AU - Lin, Jennifer

AU - Hunt, Steven

AU - Rich, Stephen S.

AU - Arnett, Donna K.

AU - Myers, Richard H.

AU - Eckfeldt, John

AU - Williams, Roger R.

AU - Province, Michael A.

PY - 2000

Y1 - 2000

N2 - A major gene effect on the fasting insulin level and insulin resistance has been suggested in previous studies. Several candidate genes for insulin resistance in rare syndromes have been proposed. However, there has been limited success in finding genes for common forms of insulin resistance. There is accumulating evidence of a relationship between insulin resistance and a disturbance of free fatty acid (FFA) metabolism. The very-low-density lipoprotein (VLDL) receptor, which is associated with FFA metabolism, could serve as a possible candidate gene for insulin resistance. We performed linkage analyses between the VLDL receptor gene and fasting insulin and the homeostasis model assessment (HOMA) insulin resistance index (fasting insulin · fasting glucose/22.5) in 1,050 sibpairs participating in the phase II physical examination of the National Heart, Lung, and Blood Institute Family Heart Study (FHS). Data analyses were completed using the SIBPAL component of the SAGE software package (SAGE, Statistical Analysis for Genetic Epidemiology, Version 3.1; Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, 1997). We did not find evidence for linkage of the fasting insulin or the HOMA insulin resistance index with a polymorphic marker at the VLDL locus (P = .316 and .402, respectively). Adjustment of fasting insulin and the HOMA insulin resistance index for the body mass index (BMI) did not change the results (P = .319 and .472, respectively). In conclusion, no evidence was found for a linkage between a locus controlling the fasting insulin level or HOMA insulin resistance index and a VLDL polymorphism in the present study. Additional adjustment of fasting insulin or the HOMA insulin resistance index for the BMI did not change the linkage results significantly. (C) 2000 by W.B. Saunders Company.

AB - A major gene effect on the fasting insulin level and insulin resistance has been suggested in previous studies. Several candidate genes for insulin resistance in rare syndromes have been proposed. However, there has been limited success in finding genes for common forms of insulin resistance. There is accumulating evidence of a relationship between insulin resistance and a disturbance of free fatty acid (FFA) metabolism. The very-low-density lipoprotein (VLDL) receptor, which is associated with FFA metabolism, could serve as a possible candidate gene for insulin resistance. We performed linkage analyses between the VLDL receptor gene and fasting insulin and the homeostasis model assessment (HOMA) insulin resistance index (fasting insulin · fasting glucose/22.5) in 1,050 sibpairs participating in the phase II physical examination of the National Heart, Lung, and Blood Institute Family Heart Study (FHS). Data analyses were completed using the SIBPAL component of the SAGE software package (SAGE, Statistical Analysis for Genetic Epidemiology, Version 3.1; Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, 1997). We did not find evidence for linkage of the fasting insulin or the HOMA insulin resistance index with a polymorphic marker at the VLDL locus (P = .316 and .402, respectively). Adjustment of fasting insulin and the HOMA insulin resistance index for the body mass index (BMI) did not change the results (P = .319 and .472, respectively). In conclusion, no evidence was found for a linkage between a locus controlling the fasting insulin level or HOMA insulin resistance index and a VLDL polymorphism in the present study. Additional adjustment of fasting insulin or the HOMA insulin resistance index for the BMI did not change the linkage results significantly. (C) 2000 by W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=12944305880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944305880&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 293

EP - 297

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 3

ER -